Novo Nordisk’s new drug IDegLira is a fixed-ratio combination of insulin degludec and the glucagonlike perptide-1 (GLP-1) agonist liraglutide. It combines the effects of insulin degludec and liraglutide in a once daily injection.
Read more
More Information on a Novel Insulin/GLP-1 Combo
Posted in Drugs Glucose & Insulin